EVOMMUNE INC (EVMN) Forecast, Price Target & Analyst Ratings

NYSE:EVMN • US30054Y1073

Current stock price

21.99 USD
-0.99 (-4.31%)
At close:
21.53 USD
-0.46 (-2.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EVOMMUNE INC (EVMN).

Forecast Snapshot

Consensus Price Target

Price Target
$55.08
+ 150.48% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.74
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.14%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$55.08
Upside
+ 150.48%
From current price of $21.99 to mean target of $55.08, Based on 14 analyst forecasts
Low
$48.48
Median
$54.06
High
$68.25

Price Target Revisions

1 Month
37.87%
3 Months
N/A

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for EVMN. The average price target is 55.08 USD. This implies a price increase of 150.48% is expected in the next year compared to the current price of 21.99.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EVMN Current Analyst RatingEVMN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

EVMN Historical Analyst RatingsEVMN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -2 -1 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.14%
EVMN was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about EVMN.
In the previous month the buy percentage consensus was at a similar level.
EVMN was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-10HC Wainwright & Co.Maintains Buy -> Buy
2026-01-22OppenheimerInitiate Outperform
2026-01-08Raymond JamesInitiate Strong Buy
2026-01-06HC Wainwright & Co.Initiate Buy
2025-12-01Leerink PartnersInitiate Outperform
2025-12-01Cantor FitzgeraldInitiate Overweight
2025-12-01William BlairInitiate Outperform
2025-12-01Evercore ISI GroupInitiate Outperform
2025-12-01Morgan StanleyInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.74
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
EVMN revenue by date.EVMN revenue by date.
5M7M
40.00%		13.26M
89.43%
-100.00%
EBITDA
YoY % growth
EVMN ebitda by date.EVMN ebitda by date.
-36.85M-68.726M
-86.50%		-79.653M
-15.90%		-113.671M
-42.71%		-142.283M
-25.17%
EBIT
YoY % growth
EVMN ebit by date.EVMN ebit by date.
-37.85M-70.013M
-84.97%		-76.055M
-8.63%		-100.8M
-32.54%		-136.782M
-35.70%
Operating Margin
EVMN operating margin by date.EVMN operating margin by date.
-757.00%-1,000.19%-573.56%N/AN/A
EPS
YoY % growth
EVMN eps by date.EVMN eps by date.
N/AN/A-4.21-2.82
33.00%		-3.26
-15.40%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.74-0.69-0.72-0.59
58.63%		-0.78
-4.35%		-0.81
-17.04%		-0.83
-14.08%		-0.83
-39.66%
Revenue
Q2Q % growth
-100.00%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-26.816M-24.837M
34.68%		-26.75M-21.165M
13.93%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EVMN Yearly Revenue VS EstimatesEVMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M 8M 10M
EVMN Yearly EPS VS EstimatesEVMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-12.77%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-26.67%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EVOMMUNE INC / EVMN Forecast FAQ

What do analysts expect the price target to be for EVOMMUNE INC (EVMN)?

14 analysts have analysed EVMN and the average price target is 55.08 USD. This implies a price increase of 150.48% is expected in the next year compared to the current price of 21.99.

What are the consensus estimates for EVOMMUNE INC (EVMN) next earnings?

The consensus EPS estimate for the next earnings of EVOMMUNE INC (EVMN) is -0.74 USD and the consensus revenue estimate is 0 USD.

Can you provide the expected long term growth rate for EVOMMUNE INC stock?

The expected long term growth rate for EVOMMUNE INC (EVMN) is -25.99%.